GB929377A - Foot and mouth disease implantation preparations - Google Patents

Foot and mouth disease implantation preparations

Info

Publication number
GB929377A
GB929377A GB4825/61A GB482561A GB929377A GB 929377 A GB929377 A GB 929377A GB 4825/61 A GB4825/61 A GB 4825/61A GB 482561 A GB482561 A GB 482561A GB 929377 A GB929377 A GB 929377A
Authority
GB
United Kingdom
Prior art keywords
foot
mouth disease
retarder
implantation body
resorbable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4825/61A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CARL PETER VARNET
Original Assignee
CARL PETER VARNET
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CARL PETER VARNET filed Critical CARL PETER VARNET
Priority to GB4825/61A priority Critical patent/GB929377A/en
Publication of GB929377A publication Critical patent/GB929377A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

A solid implantation body for immunization against foot and mouth disease is prepared by compressing a foot and mouth disease vaccine in powder form with a resorbable vehicle, which when compressed is capable of intimately bonding the particles of the vaccine, to form the implantation body and the implantation body is preferably given an incomplete coating of a resorption retarder. Compression may be at 50 to 1000 kg./cm.2 and the retarder, e.g. a synthetic resin, may be applied by spraying. The body may be oblong and may have retarder-free areas at one or both of its ends. Specified resorbable vehicles are cholesterol, stearic acid, zinc oxide or mixtures thereof.
GB4825/61A 1961-02-09 1961-02-09 Foot and mouth disease implantation preparations Expired GB929377A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB4825/61A GB929377A (en) 1961-02-09 1961-02-09 Foot and mouth disease implantation preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4825/61A GB929377A (en) 1961-02-09 1961-02-09 Foot and mouth disease implantation preparations

Publications (1)

Publication Number Publication Date
GB929377A true GB929377A (en) 1963-06-19

Family

ID=9784507

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4825/61A Expired GB929377A (en) 1961-02-09 1961-02-09 Foot and mouth disease implantation preparations

Country Status (1)

Country Link
GB (1) GB929377A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541001B1 (en) 1999-08-24 2003-04-01 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541001B1 (en) 1999-08-24 2003-04-01 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US7192588B2 (en) 1999-08-24 2007-03-20 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same

Similar Documents

Publication Publication Date Title
GB1521936A (en) Locking mechanism for safety equipment boxes
GB1302671A (en)
DE3273501D1 (en) Continuous release pharmaceutical compositions
MX9702357A (en) Spray-dried microparticles as therapeutic vehicles.
MY109744A (en) Direct compression cholestyramine tablet and solvent-free coating therefor.
GR3005768T3 (en)
AU7679787A (en) Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor
GB1209852A (en) Improvements in or relating to apparatus for loading refuse
GB890548A (en) An improved fastening device
GB929377A (en) Foot and mouth disease implantation preparations
ZA883294B (en) Deodorant
MY103835A (en) Thixotropic cement compositions.
GB987301A (en) Aerosol compositions
ES2059418T3 (en) ANTIGEN ASSOCIATED WITH HUMAN CARCINOMA AND ANTIBODY ASSOCIATED WITH ANTIGEN.
WO1991010735A3 (en) Human receptor of tsh. sequence coding for such receptor
GB941239A (en) Improvements in valves
GB1066927A (en) New cosmetic products
GB1203337A (en) Safety fasteners
GB514979A (en) Deodorant powder
US3058883A (en) Anti-aphthous preparation
Tomomatsu A serological study of experimental dermatomycoses, using an antigen prepared from fungus mechanically disintegrated. V. Production of humoral antibody and skin hypersensitivity in test-animals and man during griseofulvin-therapy
JPS5382950A (en) Clutch
FR2042569A1 (en) Antiseborrhoeic cysteine derivs in permanent - waving of hair
FR2029268A5 (en) Preparation of diagnostic soln for rheumatism - serum reaction
CA632013A (en) Hook for facial tissue box and the like